EntryPoint Capital’s Clorox CLX Stock Holding History

EntryPoint Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$633K	Buy	+6,632	New	+$637K	0.15%	231
2024 Q2	–	Sell	-254	Closed	-$38.9K	–	1465
2024 Q1	$38.9K	Buy	+254	New	+$37.9K	0.03%	870

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

EntryPoint Capital's CLX Position: Q2 2026 in Review

EntryPoint Capital opened a new position in Clorox (CLX) in Q2 2026: 6,632 shares worth $633K. The stake represents 0.15% of the portfolio and ranks #231 among its holdings. This is a return to the name: EntryPoint Capital previously reported a position in CLX as recently as Q1 2024.

EntryPoint Capital first reported a position in CLX in Q1 2024 and has held it in 2 quarters since. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

EntryPoint Capital held 6,632 shares of Clorox worth $633K as of Q2 2026.
Clorox was a new EntryPoint Capital position in Q2 2026.
Clorox made up 0.15% of EntryPoint Capital's portfolio in Q2 2026, its #231 holding.
EntryPoint Capital first reported a position in Clorox in Q1 2024 and has held it in 2 quarters since.
1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.